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ABSTRACT
Aim: This study quantified the impact of perinatal predictors and medical centre on the
outcome of very low-gestational-age neonates (VLGANs) born at <32 completed weeks
in Switzerland.
Methods: Using prospectively collected data from a 10-year cohort of VLGANs, we
developed logistic regression models for three different time points: delivery, NICU
admission and seven days of age. The data predicted survival to discharge without severe
neonatal morbidity, such as major brain injury, moderate or severe bronchopulmonary
dysplasia, retinopathy of prematurity (≥stage three) or necrotising enterocolitis (≥stage
three).
Results: From 2002 to 2011, 6892 VLGANs were identified: 5854 (85%) of the live-born
infants survived and 84% of the survivors did not have severe neonatal complications.
Predictors for adverse outcome at delivery and on NICU admission were low gestational
age, low birthweight, male sex, multiple birth, birth defects and lack of antenatal
corticosteroids. Proven sepsis was an additional risk factor on day seven of life. The medical
centre remained a statistically significant factor at all three time points after adjusting for
perinatal predictors.
Conclusion: After adjusting for perinatal factors, the survival of Swiss VLGANs without
severe neonatal morbidity was strongly influenced by the medical centre that treated them.
INTRODUCTION
Survival rates and survival without morbidity increase
sharply with gestational age (GA) among very low-GA
neonates (VLGANs) born at <32 completed weeks, and GA
has traditionally been used as the sole outcome predictor.
More recently, models that have included perinatally
known factors, such as estimated foetal weight, gender,
single or multiple birth, antenatal corticosteroid (ANC)
administration and delivery mode, have been shown to
increase the accuracy of predicting survival (1–3).
Variations in the survival rates of preterm neonates have
been observed between centres providing health care in
several populations and networks (4–7). Factors contribut-
ing to these differences in outcome have included the
inherent risk of the patient population served, the local
approach towards primary nonintervention at the border of
viability and/or the effectiveness of the patient care deliv-
ered at a particular medical centre. Despite the availability
of national guidelines on perinatal care at the limit of
Abbreviations
ANC, Antenatal corticosteroids; BPD, Bronchopulmonary dys-
plasia; CI, Confidence interval; GA, Gestational age; NICU,
Neonatal intensive care unit; NEC, Necrotising enterocolitis; OR,
Odds ratio; PIVH, Periventricular/intraventricular haemorrhage;
PVL, Periventricular leucomalacia; ROP, Retinopathy of prema-
turity; VLGANs, Very low-gestational-age neonates.
Key notes
 This study quantified the impact of perinatal predictors
and medical centre on the outcome of very low-
gestational-age neonates (VLGANs).
 Using prospectively collected data, we identified 6892
VLGANs born in Switzerland at <32 weeks of gestation
between 2002 and 2011.
 Important predictors for adverse outcomes were
patient-level factors, obstetrical interventions, proven
sepsis in the first week of life and the medical centre
where the neonate was treated.
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viability, between 22 and 26 completed weeks of gestation
(8), survival rates vary widely across the nine tertiary level
perinatal centres in Switzerland, even after adjusting for
important patient-related factors (9,10).
The chance of survival changes rapidly throughout the
first week of life in infants born at <32 weeks of gestation,
due to the fact that mortality is highest during the first few
days of life. Therefore, predictors for survival and short-
term morbidity may vary depending on postnatal age.
Existing models that aim to predict survival or morbidity
rates of VLGANs do not address the potential centre effect
on outcome and do not take into account the rapidly
changing chances of survival during the first few days of life.
Therefore, we sought to quantify the impact of different
perinatal predictors and medical centre on survival and
short-term morbidity at three different time points in infants
born at <32 weeks in Switzerland.
MATERIALS AND METHODS
Data sources
The Swiss Neonatal Network and Follow-Up Group main-
tains a database, the Minimal Neonatal Data Set (MNDS),
to prospectively collect anonymised information about the
demographics and outcome to the point of hospital
discharge of all live-born infants weighing between 400
and 1500 g at birth and with a GA of between 23 0/7 and
31 6/7 weeks. It covers infants born at, or transferred to,
one of the nine level III neonatal intensive care units
(NICUs) caring for VLGANs in Switzerland. Data collec-
tion and evaluation were approved by the institutional
ethical review boards and by the Swiss Federal Commission
for Privacy Protection in Medical Research. In this study,
data from the Swiss MNDS were used to analyse informa-
tion on all VLGANs of 23–31 completed weeks born alive
between January 1, 2002, and December 32, 2011.
Definition of neonatal variables
Gestational age was calculated based on ultrasound exam-
inations during the first trimester of pregnancy and defined
as the postmenstrual age in weeks and days. Birthweight
standard deviation scores (z-scores) for GA were calculated
based on the growth curves published by Voigt et al. (11).
Antenatal corticosteroids administration was considered
to have occurred if at least one dose was given prenatally.
Major congenital malformation was defined as any type of
malformation that had a severe impact on prognosis, such
as complex congenital heart disease or malformation
syndromes. Neonatal sepsis was assumed if positive blood
cultures were present. We defined major brain injury as
periventricular/intraventricular haemorrhage (PIVH) ≥
grade 3 (12) and/or cystic periventricular leucomalacia
(PVL) (13). Diagnosis of moderate or severe bronchopul-
monary dysplasia (BPD) was based on the National Insti-
tute of Child Health and Human Development consensus
definition as a requirement for supplemental oxygen and/or
mechanical respiratory support at 36 weeks of postmen-
strual age (14). Severe retinopathy of prematurity (ROP)
was defined as ≥ stage 3 as suggested by the International
Committee for the Classification of Retinopathy of Prema-
turity (15). Necrotising enterocolitis (NEC) was diagnosed
in the presence of at least intestinal pneumatosis and/or
portal venous gas (Bell’s stage ≥2) (16).
Outcome definition
The main outcome assessed was survival to discharge
without severe neonatal morbidity, in other words without
major brain injury, moderate or severe BPD, ROP ≥ stage 3
or NEC ≥ stage 2.
Time points of risk assessment
Outcome predictors were evaluated at delivery, on NICU
admission and on the seventh day of life. Infants who had
already died at a previous assessment time point were
excluded from the following assessments.
Statistical analysis
Missing data and multiple imputation
Missing data were more frequent in nonsurvivors than in
survivors, raising concerns about overestimating survival
and other bias. To prevent casewise deletion of infants from
analyses, we imputed missing predictor values using the
multivariate normal model and generated 10 completed
data sets, resulting in imputed variables of binary variables
taking on noninteger values, which were then carried
forward without performing rounding (17,18). Data were
imputed for survivors and nonsurvivors. All nonmissing
predictors and outcomes were included in the imputation
model.
Predictors
Predefined predictors with high a priori plausibility were
evaluated. The following prenatal predictors were tested
at all time points: GA, z-score for birthweight, gender,
singleton/multiple birth, ANC, mode of delivery, major
congenital malformation and the medical centre where the
infants were cared for. In addition, sepsis within the first
seven days of life was evaluated at the seventh day of life.
Model assessment and selection
The following candidate logistic regression models for the
binary outcomes of survival to discharge without severe
neonatal morbidity were evaluated for each time point:
A GA as the only predictor
B All considered predictors except medical centre
C Applying backward elimination to model B
D Model B including medical centre
E Applying backward elimination to model D.
Backward elimination was performed by dropping non-
significant predictors (p value >0.05) one at a time until all
the predictors had a p value of <0.05.
The continuous predictors GA and z-score for birth-
weight were tested for departure from linearity. Nonlinear-
ity was addressed by including GA as a categorical variable,
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by weeks, and birthweight by categorising the z-score.
Following the usual convention, z-score for birthweight
was split into ten 0.5-range categories from <2 to more
than +2.
We chose one primary model from A to E for each time
point using the following procedure: the cross-validated
c-statistic was calculated across the 10multiple imputed data
sets. This resulted in 10 c-statistics for each model, which
were combined using Rubin’s rule to provide the final cross-
validated c-statistic and confidence interval (CI) for each
model (19). For each time point, the model with the highest
cross-validated c-statistic was chosen as the final prediction
model. Calibration of the models was assessed with plots.
The models were screened for statistically significant
interactions, using the p value of the Wald test for the
interaction term <0.05. This showed that including any of
the interaction terms did not improve the cross-validated
c-statistics. However, to examine centre-to-centre differ-
ence based on GA groups, we fitted the final models to
include an interaction term for GA groups (<25 weeks,
25–27 weeks or >27 weeks) and medical centre.
Prediction
We calculated predicted survival probabilities and their
95% CIs from the combined estimates of the multiple
imputed data sets by applying Rubin’s rule (19). All
statistical analyses were performed using Stata 13 (Stata
Statistical Software: Release 13; StataCorp LP, College
Station, TX, USA).
RESULTS
Between January 1, 2002, and December 31, 2011, 6892
infants with a GA of between 23 and 31 completed weeks
were cared for at the nine level III perinatal centres in
Switzerland, and 5854 (85%) infants survived. Of all the
deaths, 394 (38%) occurred in the delivery room and
644 (62%) occurred in the NICU: 405 (63%) of the NICU
deaths occurred early, within seven days of admission, and
239 (37%) occurred after the seventh day of life. Of the
5854 survivors, 4905 (84%) survived the neonatal period
without any severe neonatal complications. Table 1 sum-
marises the characteristics of the patient population.
The cross-validated c-statistics of the five models for each
time point are listed in Table S1. The models were used for
predictions after applying backward elimination for prena-
tal and postnatal predictors, including the medical centre.
Figure S1 shows the calibration plots.
Table 2 lists the logistic regression models with the effects
of the various predictors on survival without severe neona-
tal morbidity.
The medical centre where care was provided was statis-
tically a highly significant predictor of outcome after
adjustment for prenatal and postnatal predictors. For
example, at delivery, an infant born at medical centre nine,
which had the highest overall survival rate, had an odds
ratio (OR) for survival without severe neonatal morbidity of
4.5 (95% CI 3.4–6.0), compared to reference centre one,
which had the lowest overall survival rate. This exceeded
the effect of being born at 25 weeks vs 24 weeks (OR 3.2,
Table 1 Characteristics of study population
Survivors
5854 Missing % (n)
Nonsurvivors
1038 Missing % (n)
Predictors
Gestational age in weeks and days, Mean  SD 29 2/7  14 0 (0) 26 0/7  16 0 (0)
Birthweight in grams, Mean  SD 1240  370 0 (0) 840  410 1 (10)
Female, % (n) 46 (2707) 0 (0) 45 (464) 0.1 (1)
ANC, % (n) 82 (4823) 4 (234) 52 (537) 13 (138)
Caesarean section, % (n) 78 (4595) 0.14 (8) 54 (565) 6 (62)
Major congenital malformation, % (n) 3 (201) 0 (0) 16 (164) 0 (0)
Multiples, % (n) 34 (1966) 0 (0) 25 (263) 0 (0)
Inborn, % (n) 94 (5479) 0 (0) 95 (982) 1 (12)
Sepsis within first seven days of life*, % (n) 3 (166) 2 (117) 6 (58) 23 (236)
Any missing predictor, % (n) 6 (353) 29 (300)
Outcomes, % (n)
Died in delivery room NA NA 38 (394) 0 (0)
Died after admission to NICU but before day of life seven NA NA 39 (405) 0 (0)
Died after day of life seven but before discharge NA NA 23 (239) 0 (0)
Moderate or severe BPD 9 (548) 0.2 (9) NA NA
PIVH ≥ III and/or cPVL 6 (323) 0.1 (7) NA NA
ROP ≥ stage 3 1.8 (103) 0 (0) NA NA
NEC 1.8 (108) 0 (0) NA NA
Any severe neonatal morbidity† 16 (949) 0.3 (16) NA NA
ANC = Antenatal corticosteroids; BPD = Bronchopulmonary dysplasia; cPVL = Cystic periventricular leucomalacia; NEC = Necrotising enterocolitis; NICU = Neo-
natal intensive care unit; PIVH = Periventricular/intraventricular haemorrhage; ROP = Retinopathy of prematurity.
*For infants alive on day of life seven (n = 5705).
†Any severe neonatal morbidity: moderate/severe BPD and/or PIVH ≥ grade III and/or cPVL and/or proven NEC and or ROP ≥ stage III.
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95% CI 2.2–4.6) or even being born at 27 weeks vs
25 weeks (OR 3.8, 95% CI 2.9–5.0). This association with
the centre where the infants were treated persisted on
NICU admission (OR 3.9, 95% CI 3.0–5.3) and on the
seventh day of life after an additional adjustment for proven
sepsis during the first week of life (OR 3.4, 95% CI 2.5–4.6).
When we used the model that allowed interactions
between GA groups and centres, the OR for survival
without severe morbidity at delivery for an infant born
<25 weeks in centre nine compared to centre one was
4.5 (CI 2.5–8.1). The OR for an infant born between 25
and 27 weeks was 5.3 (CI 3.0–9.3), and for an infant born
>28 weeks, it was 3.3 (CI 2.2–4.9). The corresponding
ORs for an infant on admission to the NICU were
3.4 (CI 1.89–6.5), 4.6 (CI 2.6–7.9) and 3.0 (CI 2.1–4.4),
respectively.
Gestational age-specific prediction estimates and CIs for
all time points were calculated for singleton infants without
severe malformations with favourable perinatal predictors,
namely z-score for birthweight of +0.5 to 1, female gender,
ANC, and, for the model on day of life seven, no sepsis
during first week of life and compared to singleton infants
without severe malformations and unfavourable perinatal
predictors, namely z-score for birthweight of 1 to 0.5,
Table 2 Logistic models of the multiple imputed data for different time points
Outcome
Survival without severe neonatal morbidity*
Time point
At delivery On NICU admission On day of life seven
OR (95% CI) OR (95% CI) OR (95% CI)
Gestational age
23 weeks Reference Reference Reference
24 vs 23 weeks 13.7 (3.3–57.4) 2.2 (0.61–8.0) 2.6 (0.64–10.3)
25 vs 24 weeks 3.2 (2.2–4.6) 2.3 (1.54–3.3) 1.93 (1.27–2.9)
26 vs 25 weeks 2.3 (1.71–2.97) 2.2 (1.71–3.0) 2.0 (1.48–2.7)
27 vs 26 weeks 1.69 (1.32–2.2) 1.65 (1.30–2.1) 1.55 (1.19–2.0)
28 vs 27 weeks 1.74 (1.36–2.2) 1.70 (1.34–2.2) 1.61 (1.25–2.1)
29 vs 28 weeks 1.29 (1.01–1.66) 1.31 (1.03–1.67) 1.24 (0.96–1.60)
30 vs 29 weeks 1.67 (1.3–2.14) 1.63 (1.28–2.1) 1.66 (1.28–2.16)
31 vs 30 weeks 1.79 (1.37–2.3) 1.68 (1.30–2.2) 1.67 (1.26–2.2)
BW (z-score)
<2 0.16 (0.10–0.24) 0.17 (0.11–0.25) 0.22 (0.14–0.35)
2 to 1.5 0.37 (0.27–0.51) 0.39 (0.28–0.53) 0.46 (0.33–0.66)
1.5 to 1 0.51 (0.39–0.65) 0.52 (0.40–0.67) 0.57 (0.43–0.76)
1 to 0.5 0.69 (0.55–0.86) 0.70 (0.56–0.86) 0.76 (0.60–0.96)
0.5 to 0 0.94 (0.77–1.15) 0.94 (0.77–1.14) 0.92 (0.74–1.15)
0 to 0.5 Reference Reference Reference
0.5 to 1 1.11 (0.88–1.39) 1.08 (0.86–1.34) 1.04 (0.82–1.33)
1 to 1.5 1.27 (0.91–1.77) 1.29 (0.94–1.77) 1.34 (0.93–1.93)
1.5 to 2 0.84 (0.50–1.41) 0.96 (0.57–1.61) 1.06 (0.57–1.96)
>2 0.14 (0.07–2.63) 0.22 (0.11–0.45) 0.69 (0.22–2.2)
Prenatal steroids 1.60 (1.32–1.94) 1.4 (1.17–1.70) –
Female 1.39 (1.21–1.59) 1.44 (1.26–1.65) 1.47 (1.27–1.69)
Caesarean section – – –
Multiples 1.17 (1.01–1.36) 1.22 (1.06–1.41) 1.27 (1.08–1.49)
Birth defect 0.19 (0.15–0.25) 0.24 (0.18–0.31) 0.43 (0.31–0.60)
Sepsis first seven days of life NA NA 0.49 (0.35–0.70)
Centre
1 Reference Reference Reference
2 1.68 (1.32–2.1) 1.54 (1.22–1.93) 1.34 (1.05–1.72)
3 2.0 (1.50–2.7) 1.89 (1.42–2.51) 1.66 (1.21–2.3)
4 1.26 (0.87–1.83) 1.14 (0.80–1.63) 1.02 (0.71–1.51)
5 1.67 (1.33–2.1) 1.38 (1.11–1.71) 1.17 (0.92–1.48)
6 2.1 (1.55–2.8) 1.89 (1.43–2.5) 1.45 (1.08–1.94)
7 2.1 (1.68–2.55) 1.89 (1.53–2.3) 1.48 (1.12–1.86)
8 2.8 (2.1–3.6) 2.6 (2.0–3.5) 2.1 (1.58–2.9)
9 4.5 (3.4–6.0) 3.9 (3.0–5.3) 3.4 (2.5–4.6)
ANC = Antenatal corticosteroids; BPD = Bronchopulmonary dysplasia; cPVL = Cystic periventricular leucomalacia; NEC = Necrotising enterocolitis; NICU = Neo-
natal intensive care unit; PIVH = Periventricular/intraventricular haemorrhage; ROP = Retinopathy of prematurity.
*Severe neonatal morbidity: moderate/severe BPD and/or PIVH ≥ grade III/IV intracranial haemorrhage and/or cPVL and/or proven NEC and/or ROP ≥ stage III.
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male gender, no ANC, and, for the model on the seventh
day of life, proven sepsis during first week of life.
Figure 1a–c and the corresponding Table S2a–c illustrate
the above-mentioned predictions for the entire country,
using the model without the centre as a predictor, and the
centres with the highest and lowest predicted rates of
survival without severe neonatal morbidity – centres one
and nine – for the three time points. Findings were similar
if only survival to discharge was examined (Fig. 2a–c,
Table S3a–c).
As GA increased, the impact of perinatal risk factors,
as well as medical centre on survival and survival without
severe neonatal morbidity, became less pronounced,
although differences persisted up to 31 weeks of gestation.
DISCUSSION
Our study quantifies the impact of different prenatal and
postnatal risk factors and medical centre on the probability
of survival to discharge without any severe neonatal
morbidity in a large national cohort of VLGANs in
Switzerland.
Our three prediction models illustrate how prognosis
changed rapidly throughout the first week of life. At the
lowest GAs – 23 and 24 completed weeks – the chances of
survival without severe neonatal morbidity increased sub-
stantially for those infants who were admitted to a NICU
(Fig. 1a,b). This is not surprising, as delivery room deaths in
borderline viable infants are usually the result of primary
nonintervention rather than failed resuscitation. At the limit
of viability, such an approach invariably leads to death
(20–22). Despite the availability of national guidelines or
legal definitions of human viability, considerable centre-to-
centre differences in the initiation of life-sustaining thera-
pies at the limit of viability were documented in many
countries and are likely to reflect a particular NICU’s
culture (23).
In the present study, chances for survival without severe
neonatal morbidity were substantially reduced for all
VLGANs who sustained an episode of sepsis during the
first week of life (Table 2, Fig. 1c).
Finally, our study quantifies centre-to-centre outcome
variability in this vulnerable population in Switzerland
(Figs 1a–c and 2a–c, Tables S2a–c and S3a–c). The fact
that centre-to-centre differences existed for both survival
to discharge without severe neonatal morbidity and sur-
vival to discharge suggests that more proactive treatment
approaches resulted in higher survival rates without
increasing short-term morbidity rates. Over the last decade,
several publications have addressed centre-to-centre differ-
ences in multiple populations and networks (4,5,7,24,25).
Three factors provide possible explanations for centre
differences: first, the inherent risk of the patient population
served by a centre; second, the approach of any given centre
towards primary nonintervention in infants born at the
border of viability; and third, the effectiveness of the patient
care delivered at a particular centre. In our study, the
association between medical centre and survival without
severe neonatal morbidity remained substantial after
adjusting for important patient-level factors (Table 2).
This is consistent with centre-to-centre outcome differences
reported by other networks that could not be explained by
A
B
C
Figure 1 Prediction of survival without severe neonatal morbidity at the time
of birth (a), at the time of NICU admission (b) and on day of life seven (c)
(favourable risk factors: z-score for BW +0.5 to 1, female, antenatal
corticosteroids (ANC), and, for the model on day of life seven, no proven
sepsis during first week of life; unfavourable risk factors: z-score for BW 0.5 to
1, male, no ANC, and, for the model on day of life seven, proven sepsis during
first week of life).
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differences in patient demographics (5), health insurance
coverage (4) or hospital case load (26,27). These findings
suggest that differences in centre-specific neonatal practices
strongly influence outcome (24,27,28).
The magnitude of the centre-to-centre outcome differ-
ences in our study is comparable to the one described by
Lee et al. (4) for Canadian NICUs and by Vohr et al. (5)
for the National Institutes for Child Health and Develop-
ment Neonatal Research Network (NICHD NRN) centres.
Alleman et al. (24) confirmed these findings for a more
recent cohort of extremely low-birthweight infants cared
for by the NICHD NRN and found that centre interven-
tion rates were statistically significant, but only when it
came to predicting mortality for infants <25 weeks GA.
This contrasts with the results of our study, where centre-
to-centre outcome variability extended beyond the most
immature infants, and primary noninterventions in infants
born at the border of viability did not entirely explain the
observed centre-to-centre differences. A study by Smith
et al. from the NICHD NRN found similar results to our
study. They reported that that centres with a more
aggressive approach to care for infants born at 22–
24 weeks also had reduced rates of death, death or ROP,
death or NEC, death or late-onset sepsis, and death or
neurodevelopmental impairment for more mature infants
born at 25–27 weeks (29).
LIMITATIONS
Because data were more frequently missing in nonsurvivors,
casewise deletion of infants with missing data from the
prediction models would have overestimated survival
probabilities. We used multiple imputation to reduce bias
due to missing data, but our estimate of the associations
could still be biased if missing data depended not only on
the variables we used to impute missing values, but also on
the unknown missing values themselves (30). A 10-fold
cross-validation was used to internally validate the models
and avoid overfitting, but the models were not externally
validated. Furthermore, we cannot exclude the fact that
some of the centre-to-centre differences were a chance
finding due to multiple comparisons between the nine
NICUs. Our study does not provide information on long-
term neurodevelopmental impairment. However, severe
neonatal morbidities, such as major brain injuries, moder-
ate/severe BPD, proven NEC and severe ROP, are known
to correlate with long-term neurodevelopmental outcomes
(31,32). Finally, the study design did not allow us to analyse
trends over time.
CONCLUSION
There was strong evidence for wide centre-to-centre out-
come variability in rates of survival without severe neonatal
morbidity among VLGANs in Switzerland over a time
period of 10 years that could not be explained by patient-
level factors. The observed outcome differences were not
restricted to infants born at the limit of viability, but
extended to more mature infants and persisted after the
first week of life. Identifying and implementing potentially
better practices in perinatal care may influence important
outcomes.
A
C
B
Figure 2 Prediction of survival to discharge at the time of birth (a), at the time
of NICU admission (b) and on day of life seven (c) (favourable risk factors: z-
score for BW +0.5 to 1, female, antenatal corticosteroids (ANC), and, for the
model on day of life seven, no proven sepsis during first week of life;
unfavourable risk factors: z-score for BW 0.5 to 1, male, no ANC, and, for
the model on day of life seven, proven sepsis during first week of life).
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SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article:
Figure S1 Calibration plots for the final models for
predicting survival without severe neonatal morbidity at
different time points.
Table S1 10-fold cross-validated c-statistics for different
time points and models using the multiple imputed data set.
Table S2 (a–c) Predictors for survival without any severe
neonatal morbidity* at the time of delivery (a), at the time of
NICU admission (b) and on the seventh day of life (c) for
inborn singleton infants without major birth defects.
Table S3 (a–c) Predictors for survival to discharge at the
time of delivery (a), at the time of NICU admission (b) and
on the seventh day of life (c) for inborn singleton infants
without major birth defects.
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